Factors influencing outcome of prednisone dose reduction in myasthenia gravis

M. A. Miano, T. M. Bosley, T. D. Heiman-Patterson, J. Reed, R. C. Sergott, P. J. Savino, N. J. Schatz

Research output: Contribution to journalArticle

Abstract

We reviewed retrospectively 114 prednisone dose reduction attempts in 63 myasthenic patients. Dose reduction was considered successful if a patient remained asymptomatic for more than 1 year on no prednisone or a stable low dose of prednisone. Successful dose reduction attempts were more common in patients taking azathioprine, but thymectomy did not influence taper outcome. Slower rate of dose reduction and higher ending dose of prednisone improved the chance of success.

Original languageEnglish (US)
Pages (from-to)919-921
Number of pages3
JournalNeurology
Volume41
Issue number6
DOIs
StatePublished - Jun 1991

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Factors influencing outcome of prednisone dose reduction in myasthenia gravis'. Together they form a unique fingerprint.

  • Cite this

    Miano, M. A., Bosley, T. M., Heiman-Patterson, T. D., Reed, J., Sergott, R. C., Savino, P. J., & Schatz, N. J. (1991). Factors influencing outcome of prednisone dose reduction in myasthenia gravis. Neurology, 41(6), 919-921. https://doi.org/10.1212/wnl.41.6.919